Trommsdorff GmbH & Co. KG   Report issue

For profit Phase 3
Founded: Alsdorf Germany (1797)
Status: Left NME R&D (2013)

Organization Overview

First Clinical Trial
2003
NCT00251134
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2003

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

icosapent ethyl (vascepa) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Death (Phase 3)

Death, Sudden, Cardiac (Phase 3)

Infarction (Phase 3)

Myocardial Infarction (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1